Gong L - Search Results

1

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.

Jing Z, Gong L, Xie CY, Zhang L, Su HF, Deng X, Wu SX. Jing Z, et al. Among authors: gong l. Radiother Oncol. 2009 Dec;93(3):468-73. doi: 10.1016/j.radonc.2009.08.008. Epub 2009 Sep 8. Radiother Oncol. 2009. PMID: 19744737

2

Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Nan KJ, Jing Z, Gong L. Nan KJ, et al. Among authors: gong l. World J Gastroenterol. 2004 May 15;10(10):1425-30. doi: 10.3748/wjg.v10.i10.1425. World J Gastroenterol. 2004. PMID: 15133847 Free PMC article.

3

SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.

Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J, Chen G, Gong L. Jing Z, et al. Among authors: gong l. Cancer Med. 2020 Jun;9(12):4324-4338. doi: 10.1002/cam4.3020. Epub 2020 Apr 23. Cancer Med. 2020. PMID: 32324343 Free PMC article.

4

The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer.

Jing Z, Chen K, Gong L. Jing Z, et al. Among authors: gong l. Int J Nanomedicine. 2021 Sep 3;16:6115-6127. doi: 10.2147/IJN.S321555. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34511909 Free PMC article. Review.

5

Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1.

Li Y, Zhou L, Huang Z, Yang Y, Zhang J, Yang L, Xu Y, Shi J, Tang S, Yuan X, Xu J, Li Y, Han X, Li J, Liu Y, Sun Y, Jin X, Xiao X, Wang B, Lin Q, Zhou Y, Song X, Cui Y, Hu L, Song Y, Bao J, Gong L, Gershwin ME, Zuo X, Yan H, Zou Z, Tang R, Ma X; Chinese AIH Consortium. Li Y, et al. Among authors: gong l. JHEP Rep. 2023 Oct 5;6(1):100926. doi: 10.1016/j.jhepr.2023.100926. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38089552 Free PMC article.

6

Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control.

Liu J, Zhang H, Kong J, Liu S, Chen L, Jiang Y, Wang J, Zhang B, Ye X, Gong L, Zhou X, Chen G, Li J, Pan X, Zhang H, Shi J. Liu J, et al. Among authors: gong l. J Med Virol. 2023 Oct;95(10):e29173. doi: 10.1002/jmv.29173. J Med Virol. 2023. PMID: 37822119

7

Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD).

Shao L, Liu J, Song Y, Yang W, Gong L, Lyu Z, Zhu Q, Fu J, Li J, Shi J. Shao L, et al. Among authors: gong l. Clin Chim Acta. 2023 Jan 1;538:203-210. doi: 10.1016/j.cca.2022.12.014. Epub 2022 Dec 20. Clin Chim Acta. 2023. PMID: 36549641 Free article.

8

Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in ABCB4 in China.

Cheng J, Gong L, Mi X, Wu X, Zheng J, Yang W. Cheng J, et al. Among authors: gong l. Front Med (Lausanne). 2022 Dec 8;9:962408. doi: 10.3389/fmed.2022.962408. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569137 Free PMC article.

9

Time-varying 3D optical torque via a single beam.

Wu YJ, Zhuang JH, Yu PP, Liu YF, Wang ZQ, Li YM, Qiu CW, Gong L. Wu YJ, et al. Among authors: gong l. Nat Commun. 2025 Jan 11;16(1):593. doi: 10.1038/s41467-024-55781-y. Nat Commun. 2025. PMID: 39799144

10

Calcified chondroid mesenchymal neoplasm: a clinicopathological and molecular analysis.

Feng X, Wang S, Wei J, Li W, Wang S, Guo P, Guo C, Hao W, Dai H, Gong L. Feng X, et al. Among authors: gong l. J Clin Pathol. 2025 Jan 11:jcp-2024-209806. doi: 10.1136/jcp-2024-209806. Online ahead of print. J Clin Pathol. 2025. PMID: 39798957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,189 results

Search Page

Filters